Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOT VAC | VAC | 3.27% |
| BLOOMIN BRAN | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
While the European banks are seeking to reduce their balance sheets, Citigroup Inc. (C - Analyst Report) has strengthened its European distressed-debt sourcing arm, according to a Bloomberg report.
The unit, which consisted of only one employee in the prior month, now has strength of six employees who are involved in searching for distressed assets from other European banks. Of the six, two are solely committed to this effort.
The strengthening of Citi’s team would assist banking clients with their deleveraging process. Amidst the Eurozone crisis and the need to build up capital levels to satisfy regulator’s stricter capital norms, European banks are slashing their balance sheet.
This retreat by the European banks is opening up avenues for their U.S. counterparts like Citi and Wells Fargo & Co. (WFC - Analyst Report), who are capitalizing on the deleveraging activities. In fact, Wells Fargo is active on this front and has been making a number of strategic asset acquisitions from the European counterparts.
Citi has already implemented strategic reengineering efforts in its business and has been shedding non-core assets over the past few years. Solidifying its core franchisee is a priority and trimming of assets frees up its resources so that they can be deployed in its core business.
We believe that capitalizing on the deleveraging activities of the European banks is a strategic fit for Citi and its expansion of European distressed-debt sourcing arm would offer opportunities to augment its top line. It is an attractive business opportunity and this environment furnishes it with significant scope to increase its scale and strengthen its market share and hence we remain encouraged.
Citi currently retains its Zacks #3 Rank, which translates into a short-term Hold rating. Considering its fundamentals, we have a long-term Neutral recommendation on the stock.
Read the full reports :
Analyst Report on C
Analyst Report on WFC